Literature DB >> 11253905

Descriptive epidemiology of male breast cancer in Osaka, Japan.

N Tajima1, H Tsukuma, A Oshima.   

Abstract

Male breast cancer is rare. The total number of incidence in Osaka for the period of 1966-95 was 182. Male-to-female ratio for breast cancer incidence was 1:164 in Osaka during this period. Mean age of the male breast cancer incidence was 63.3. The numbers of incidence and the crude incidence rates for male breast cancer have increased during the last 3 decades, while the age-standardized rates have remained constant. The age-specific incidence rates for males showed a gradual increase with age, while those for females showed a steep increase beginning at twenty years of age and a peak around 45-49 or 50-54 years old. The age-standardized incidence rates of male breast cancer were lower in Japan than in European countries and North America, as were those of female breast cancer. Distributions of the histological type and the extent of disease were not significantly different between males and females. Relative 5-year survival for the male breast cancer was, however, lower than that for the female, especially in the "regional" stage and "distant" stage. Further studies on the sex-difference in survival will be mandatory based on high-quality hospital cancer registries' data, which provide detailed information on the clinical stage and treatment.

Entities:  

Mesh:

Year:  2001        PMID: 11253905     DOI: 10.2188/jea.11.1

Source DB:  PubMed          Journal:  J Epidemiol        ISSN: 0917-5040            Impact factor:   3.211


  7 in total

1.  Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration.

Authors:  Jennifer L Gnerlich; Anjali D Deshpande; Donna B Jeffe; Susmitha Seelam; Eric Kimbuende; Julie A Margenthaler
Journal:  Ann Surg Oncol       Date:  2010-12-14       Impact factor: 5.344

2.  Profile of Male Breast Cancer in Makkah Region of Saudi Arabia: A 4-Year Retrospective Analysis of Radiology and Histopathology.

Authors:  Muhammad Saeed; Bothaina Mohammed Abdulshakour; Najwa Abdalkabeer A Bantan; Afnan Hisham Falemban; Munir Abdulla; Ehab M Melibary; Ahmad H Mufti; Mohiuddin M Taher
Journal:  Int J Breast Cancer       Date:  2022-06-22

3.  Clinicopathologic characteristics and survival of male breast cancer.

Authors:  Dongying Liu; Guangru Xie; Ming Chen
Journal:  Int J Clin Oncol       Date:  2013-05-03       Impact factor: 3.402

4.  A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC).

Authors:  Xing-Fei Yu; Hong-Jian Yang; Yang Yu; De-Hong Zou; Lu-Lu Miao
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

5.  Male breast cancer: thirteen years experience of a single center.

Authors:  Sami Akbulut; Ilker Arer; Alper Kocbiyik; Mahmut Can Yağmurdur; Hamdi Karakayalı; Mehmet Haberal
Journal:  Int Semin Surg Oncol       Date:  2009-02-05

Review 6.  The thyroid, iodine and breast cancer.

Authors:  Peter P A Smyth
Journal:  Breast Cancer Res       Date:  2003-07-29       Impact factor: 6.466

Review 7.  Current state of surgical management for male breast cancer.

Authors:  Vladimir Popa-Nimigean; Muneer Ahmed
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.